Medicines List

Description

Jamax contains the active substance selegeline and belongs to the group of antiparkinsonian medicinal products.

Indications

Jamax is indicated for the treatment of Parkinson’s disease and symptomatic parkinsonism, alone or in combination with levodopa (another medicine used to treat Parkinson’s disease), with or without a peripheral enzyme inhibitor. In the early stages of Parkinson’s disease, Jamax can be used to delay the start of treatment with levodopa (with or without an enzyme inhibitor).
Upon treatment with Jamax early or moderate stage of the disease is achieved good results.
In the late stages of Parkinson’s disease, taking Jamax may increase the therapeutic effect of levodopa.

Subject to medical prescription.

Concentration and pharmaceutical form: 5 mg tablets

Description

Diclofenac belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), which are used to treat pain and inflammation.

Indications

Diclofenac-Tchaikapharma is suitable for the treatment of the following conditions:
– Rheumatic joint pain (arthritis);
– Back pain, “stiff shoulder syndrome”, “tennis elbow syndrome” and other forms of rheumatism;
– Attacks of gout;
– Sprains, strains and other injuries;
– Pain and swelling after surgery;
– Painful gynecological inflammatory conditions, including painful menstrual cramps;
– Ear, nose and throat infections.

Subject to medical prescription.

Concentration and pharmaceutical form: 50 mg gastro-resistant tablets

Description

Irinotecan is a cytostatic inhibitor of topoisomerase I, semi-synthetic derivative of kamptotecin. It is an antineoplastic agent that acts as a specific inhibitor of DNA topoisomerase I, including lesions of one strand of DNA that blocks replication fork DNA. Besides anticancer activity of Irinotecan, his most important pharmacological effect is blocking acetylcholinesterase.

Indications

Irinotecan is indicated for treatment of patients with advanced colorectal cancer:

–         in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease.

–         as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.

Subject to medical prescription

Pharmaceutical form: 20 mg/ml concentrate for solution for infusion

Description

Metamizole sodium is a nonsteroidal anti-inflammatory drug (NSAID), the group of pirazolones. It has analgesic (painkiller) and antipyretic (temperature decreasing) effect, with a weaker anti-inflammatory activity and mild antispasmodic action.

Indications

–         Pain with various origin and intensity when other agents are ineffective or contraindicated – headache, tootache, joint and muscle and inflammation; posttraumatic and postoperative pain; renal and biliary ducts, dyskinesia; upper respiratory tract inflammation of microbial or viral origin; cancer pain with WBC monitoring. In the internationally accepted cancer pain relief regimen.

Metamizole is recommended as the “last but one step” prior to administration of narcotic analgesics.

–          Elevation of high body temperature

Subject to non-medical prescription

Pharmaceutical form: 500 mg x 10 tablets